Click to Share
 

Generics Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12579199
By SMi Group
SMi are delighted to have Duncan Emerton from FirstWord present at the 7th Annual Biosimilars Europe when it returns to London on 29TH-30TH September 2016.
12569679
By SMi Group
Case studies from both Switzerland and Norway on strategic management and switching studies with two keynotes from Merck Group and the Norwegian Medicines Agency.
12555955
By SMi Group
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe, taking place on 29th & 30th September 2016 in Central London, UK.
By CPC Scientific Inc.
CPC Scientific is pleased to announce that the CPC Good Manufacturing Practice (GMP) facility in Hangzhou, China has successfully passed its fourth U.S. Food and Drug Administration (FDA) inspection.  No Form 483 observations were issued.
12468897
By SMi Group Ltd
SMi Group reports (2015.06.26, Iselin, USA): John Pakulski, Head US Biopharmaceutical Regulatory Affairs, Sandoz, will be presenting on Day 1 of the SMi’s Biosimilars & Biobetters USA 2015 conference in Iselin. Registration now open
By Eulysis
Eulysis Raises $3.2 Million to Launch the Single Vial System (SVS)
By marcus evans
Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs from leading pharmaceutical and biotech companies to discuss best practices for generic label documentation
By marcus evans
Interview with Richard DiCicco, Chairman with Harvest Moon Pharmaceuticals, on key topics to be discussed at the upcoming marcus evans 7th Product & Pipeline Enhancement for Generics Conference, on July 30-31, 2014 in Alexandria, VA
12332814
By SMi Group
Principal Global Head Generics, IMS Health, to present a keynote address at the 5th annual Biosimilars and Biobetters Conference in London
By American Conference Institute
American Conference Institute (“ACI”) is pleased to announce that Keith Flanagan, Transition Lead for Policy at the United States Food and Drug Administration’s Office of Generic Drugs will give a keynote address at ACI’s Second Annual Legal and...
12253485
By SMi Group
Creating an Innovate Plan for the USA Biosimilars Market: presentations from Sandoz, IMS Health, Bristows, PRA International, Celltrion, MedImmune, Novartis, Lonza Biologics and others
12073893
By SMi Group
SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the industry
By Generic Pharma 2.0
A new conference productivity platform, to be launched at CPhI Madrid on October 9, 2012
By Bharat Book Bureau
Bharat Book introduces a report " Generics as a Vehicle to Improve Market Access " the report offers insights into other mechanisms, such as differential pricing and price-cutting, branded generics.

All Press Releases

12579199
By SMi Group
SMi are delighted to have Duncan Emerton from FirstWord present at the 7th Annual Biosimilars Europe when it returns to London on 29TH-30TH September 2016.
12569679
By SMi Group
Case studies from both Switzerland and Norway on strategic management and switching studies with two keynotes from Merck Group and the Norwegian Medicines Agency.
12555955
By SMi Group
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe, taking place on 29th & 30th September 2016 in Central London, UK.
By CPC Scientific Inc.
CPC Scientific is pleased to announce that the CPC Good Manufacturing Practice (GMP) facility in Hangzhou, China has successfully passed its fourth U.S. Food and Drug Administration (FDA) inspection.  No Form 483 observations were issued.
12468897
By SMi Group Ltd
SMi Group reports (2015.06.26, Iselin, USA): John Pakulski, Head US Biopharmaceutical Regulatory Affairs, Sandoz, will be presenting on Day 1 of the SMi’s Biosimilars & Biobetters USA 2015 conference in Iselin. Registration now open
By Eulysis
Eulysis Raises $3.2 Million to Launch the Single Vial System (SVS)
By SMi Group Ltd
SMi's 9th annual Parallel Trade conference will take place on 9-10 February 2015 in London, United Kingdom.
By SMi Group Ltd
SMi’s 9th annual conference on Parallel Trade takes place in London, UK on 9th - 10th February 2015
By marcus evans
Inviting Heads, VPs, Directors, Managers, and Specialists of Labeling and Regulatory Affairs from leading pharmaceutical and biotech companies to discuss best practices for generic label documentation
By SMi Group Ltd
SMi Group reports (2014.08.22, London): In preparation for the 5th annual Biosimilars and Biobetters Conference, SMi Group has conducted a series of interviews with leading industry experts
By marcus evans
Interview with Richard DiCicco, Chairman with Harvest Moon Pharmaceuticals, on key topics to be discussed at the upcoming marcus evans 7th Product & Pipeline Enhancement for Generics Conference, on July 30-31, 2014 in Alexandria, VA
12332814
By SMi Group
Principal Global Head Generics, IMS Health, to present a keynote address at the 5th annual Biosimilars and Biobetters Conference in London
By American Conference Institute
American Conference Institute (“ACI”) is pleased to announce that Keith Flanagan, Transition Lead for Policy at the United States Food and Drug Administration’s Office of Generic Drugs will give a keynote address at ACI’s Second Annual Legal and...
12253485
By SMi Group
Creating an Innovate Plan for the USA Biosimilars Market: presentations from Sandoz, IMS Health, Bristows, PRA International, Celltrion, MedImmune, Novartis, Lonza Biologics and others
By SMi Group
Held in association with Interpharm | 17 July 2013, London,...
12073893
By SMi Group
SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the industry
By Generic Pharma 2.0
A new conference productivity platform, to be launched at CPhI Madrid on October 9, 2012
By Bharat Book Bureau
Bharat Book introduces a report " Generics as a Vehicle to Improve Market Access " the report offers insights into other mechanisms, such as differential pricing and price-cutting, branded generics.
By SMi Group
Trends and future market environment, how will this hinder or enhance growth and profitability?
By SMi Group
Competitive advantages of small and large companies and an outlook for the future of the UK generics market
By Bharatbook
Bharatbook added a new report on " Cancer Generics Market Analysis " which gives an overview, Demand, Supply Trends and industry analysis reports.
11795596
By SMi Group
The state of the European generics market, how will your company make a profit?
By Data3s
Data3s, a leading provider of customer relationship management solutions for the life sciences, today announced that the Czech and Slovak offices of Glenmark Pharmaceuticals Ltd. have renewed their contract with Data3s for another three years.
By Fast Market Research
New Healthcare research report from Business Monitor International is now available from Fast Market Research
By SMi Group
With billions of dollars worth of biologic drugs going off patient in the next decade, this industry is set to expand at an intensive rate, and the importance of being fully informed of how you and your business will be affected is paramount.
By Frost & Sullivan
This briefing is a must for companies planning on entering the food ingredients sector
By SMi Group
With billions of dollars worth of biologic drugs going off patient in the next decade, this industry is set to expand at an intensive rate, and the importance of being fully informed of how you and your business will be affected is paramount.
By Fast Market Research
Fast Market Research recommends "Malaysia Pharmaceuticals & Healthcare Report Q2 2011" from Business Monitor International, now available
By Fast Market Research
Recently published research from Business Monitor International, "Israel Pharmaceuticals & Healthcare Report Q2 2011", is now available at Fast Market Research
By reports-research.com
Latest research from independent analyst, Business Insights, has assessed and documented the innovative drug discovery taking place in a corporate setting in countries that constitute emerging pharmaceutical markets, primarily: -

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share